Medical Cannabis Medicines Portal, page-26

Back to the apparently vapid 'quality of management' piece.

While it seems there are a number of related, but distinct, commercial opportunities THC is pursuing, clearly the greatest potential for value/margin is in Medicinal Cannabis (surely nobody is arguing this point).

If that is the case, and the old maxim of 'past performance is the best indicator of future performance', one would expect the company has some management capability in Medicinal Cannabis or some other aspect of medical product development/management, sales, marketing etc.

But they don't.

Perhaps this is where Saci's 'witless' comment was coming from?